Escolar Documentos
Profissional Documentos
Cultura Documentos
No disclosures
Hank Gathers, 23, dies on court, HCM Thomas Herrion, 23, dies after game, HCM
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol Consensus statement of the study group of sport cardiology of the Working Group of Cardiac Rehabilitation and exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology
Since 1982, Italian government mandated annual ECG +H/P in all competitive athletes age 1235. IOC also mandates yearly EKGs and H/P in all Olympic participants.
Recommendations for interpretation of 12 lead ECG in athletes. Corrado et al EHJ (2010)31 (2):243-259
Common training ECG changes sinus brady PR prolongation Incomplete RBBB early repolarization isolated QRS voltage criteria for LVH Convex ST +T wave inv V1-V4 in black athletes Wenckebach Ectopic atrial rhythm Junctional escape rhythm
Uncommon- needs follow up T wave inversion ST depression pathologic Q LAE LAD/LAFB RAD/LPFB RVH pre-excitation LBBB/RBBB Long or short QT Brugada-like repol
For a free online training module on ECG interpretation in athletes, please visit: http://learning.bmj.com/ECGathlete
Feasibility of screening portable echocardiography-JASE May 2012 Weiner et al. JASE 2012; 25(5) 568-575.
Harvard University Athletics program Pre participation portable echocardiograms done yearly over 3 years on 510 participants. Interpretable images: 92%
MVP
Different Sports
Maron, BJ. British Journal of Sports medicine 2009;43:649-656
Endurance (cycling, marathon, swimming) : Increase oxygen consumption, cardiac output, stroke volume and decrease in PVR. mod increase in BP. PRIMARILY volume load. Power (lifting, wrestling, javelin): mild inc CO and oxygen consumption, but marked increases in BP, PVR and HR. BPs reported up to 480/350mmHg. Inc wall thickness.
What is normal?
Pelliccia et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. NEJM 1991;324:295-301
Enlarged LVEDD
Pelliccia et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite
Figure Legend:
Differentiating Between Physiology and Pathology: Athlete's Heart Versus HCM and ARVC
Black athletes have greater incidence of wall thickness >12mm (40%) vs Caucasian athletes (2-3%). Female athletes have less LV dilatation and LV wall thickness compared to male athletes even when adjusted for BSA.
Effect of detraining
Maron et al. BHJ 1993, Reduction in LV wall thickness after deconditioning in Olympic athletes. Pelliccia A, et al. Circulation 2002. Remodeling of LVH in elite athletes after long-term deconditioning.
Low EF
Abergel et al (JACC 2004): 286 Tour de France cyclists. LVDD >60mm and 12% with LVEF <52%. Abernathy et al (JACC 2003): 1282 NFL recruits screened with H+P/EKG, 156 had echo follow up. Low normal LVEF 50-60%, enlarged LV, but normal augmentation of systolic function with stress
Utility of CMR
courtesy S. Wolff
RV enlargement
Physiologic balanced and parallel RV and LV enlargement with training Especially in endurance athletes (soccer, track).
Up to 24% elite athletes have LA >40mm in PSL view Increased afib incidence has also been reported in athletes, but not strongly related to LAE (many)
Case:
18 year old during pre-sports screening with murmur noted, follow up ECG.
BC#36
Athletes with probable or definitive clinical diagnosis of HCM should be precluded from most competitive sports, with possible exception of those of lowintensity regardless of phenotype or treatment/intervention. Athletes genotype (+), phenotype (-) with no cardiac symptoms or FH of SCD are not precluded, but are recommended to have frequent serial echo, EKG, Holter, exercise stress and CMR. Athletes with abnormal 12 lead ECG, with normal 2D echo, esp with FH(+) for HCM, should undergo CMR for regional LVH undetected by echo and delayed enhancement.
MVP
BC#36 recommendations Athletes with MVP and WITHOUT these features can compete in
all competitive sports
prior syncope due to arrhythmia sustained or repetitive and Nonsustained supraventricular and/or complex ventricular tachyarrhtyhmias on Holter severe MR LV EF <50% prior embolic event
Athletes with MVP WITH any of above can compete in lowintensity competitive sports only
Summary
Pre-participation History/physical exam/+/-ECG (12point AHA guideline)
Echo findings of athletes heart-Eccentric/concentric hypertrophy, enlarged atria, RV enlargement, higher PA pressures, possibly LLN EF. Use of exercise echo/Doppler indices/CMR/detraining to differentiate between LVH and cardiomyopathy.
Follow aortic roots >4.0cm. Compare with first, not just prior year.
Bethesda Conference #36 recommendations
Thank you
?mechanism: early and rapid diastolic filling, increased diastolic volume, increased systolic contractility
Increase in PASP in athletes during intense exercise >non-athletes
BC#36 recommendations
(+)Bicuspid Aortic valve without aortic root dilatation and no sig AS/AR may participate in all competitive sports (+)BiAV with dilated aortic root 40-45mm can participate in low and mod static or low and mod dynamic competitive sports, but should avoid any sport with potential for bodily collision or trauma (+)BiAV and aortic root >45mm should participate in only low intensity competitive sport
24 year old with lens Aortic criterion (Z>/=2 above 20 years old , Z>/=3 below 20 years old, dislocation, (+)FH Marfans
or aortic dissection)
2.6cm 4.5cm
Italian National Pre participation screening package cost per athlete is $60